theGirlWithBlueHair
Bluelighter
- Joined
- Jan 20, 2016
- Messages
- 1,214
Alright. As some of you are aware a new ionotropic glutamate antagonist recently was approved. But this one is an AMPA receptor antagonist. In trials it was shown to cause dissociative effects similar to ketamine. Has anybody had a chance to try it yet? I imagine it's probably difficult to obtain but I'd really like to hear experiences and how l much it compares to NMDA antagonists like ketamine and dextromethorphan.
And as far as I can tell it's only a scheduled drug in the US! How is that possible? Why is the DEA screwing us. Every New drug that even dares to enter the brain gets a controlled substance sticker slapped on it... -_-
And if it causes these effects what are the implications for schizophrenia now that the AMPA receptor has been found to elicit similar effects. Its hard to say since it's so new and not many people have experienced it. Damn... I reeeaallly want to try this stuff...
And as far as I can tell it's only a scheduled drug in the US! How is that possible? Why is the DEA screwing us. Every New drug that even dares to enter the brain gets a controlled substance sticker slapped on it... -_-
And if it causes these effects what are the implications for schizophrenia now that the AMPA receptor has been found to elicit similar effects. Its hard to say since it's so new and not many people have experienced it. Damn... I reeeaallly want to try this stuff...